Model for individualized prediction of breast cancer risk after a benign breast biopsy

Journal of Clinical Oncology

Volumn 33, Issue 8, 2015, Pages 923-929

  Pankratz, V Shane ^a   Degnim, Amy C ^b   Frank, Ryan D ^b   Frost, Marlene H ^b   Visscher, Daniel W ^b   Vierkant, Robert A ^b   Hieken, Tina J ^b   Ghosh, Karthik ^b   Tarabishy, Yaman ^c   Vachon, Celine M ^b   Radisky, Derek C ^b   Hartmann, Lynn C ^b  

^a UNIVERSITY OF NEW MEXICO HEALTH SCIENCES CENTER   (United States)

^b MAYO CLINIC   (United States)

^c WASHINGTON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BENIGN BREAST DISEASE TO BREAST CANCER MODEL; BREAST BIOPSY; BREAST CANCER; BREAST CANCER RISK ASSESSMENT TOOL; BREAST DISEASE; CANCER RISK; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; FEMALE; FOLLOW UP; HISTOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MIDDLE AGED; MODEL; PERSONALIZED MEDICINE; PREDICTIVE VALUE; PRIORITY JOURNAL; PROBABILITY; RISK ASSESSMENT; ADOLESCENT; AGE; BIOPSY; BREAST NEOPLASMS; EARLY CANCER DIAGNOSIS; PATHOLOGY; PROCEDURES; RISK FACTOR; STATISTICAL ANALYSIS; STATISTICAL MODEL; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; BIOPSY; BREAST NEOPLASMS; DATA INTERPRETATION, STATISTICAL; EARLY DETECTION OF CANCER; FEMALE; FOLLOW-UP STUDIES; HUMANS; MIDDLE AGED; MODELS, STATISTICAL; RISK ASSESSMENT; RISK FACTORS; YOUNG ADULT;

EID: 84924860017     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2014.55.4865     Document Type: Article

References (27)

1. American Cancer Society: How many women get breast cancer? http://www.cancer.org/cancer/breastcancer/overview-guide/breast-cancer-overview-key- statistics
2. Costantino JP, Gail MH, Pee D, et al: Validation studies for models projecting the risk of invasive and total breast cancer incidence. J Natl Cancer Inst 91:1541-1548, 1999
3. Gail MH, Brinton LA, Byar DP, et al: Projecting individualized probabilities of developing breast cancer for white females who are being examined annually. J Natl Cancer Inst 81:1879-1886, 1989
4. Rockhill B, Spiegelman D, Byrne C, et al: Validation of the Gail et al. model of breast cancer risk prediction and implications for chemoprevention. J Natl Cancer Inst 93:358-366, 2001
5. Gutwein LG, Ang DN, Liu H, et al: Utilization of minimally invasive breast biopsy for the evaluation of suspicious breast lesions. Am J Surg 202:127-132, 2011
6. Dupont WD, Parl FF, Hartmann WH, et al: Breast cancer risk associated with proliferative breast disease and atypical hyperplasia. Cancer 71:1258-1265, 1993
7. Hartmann LC, Sellers TA, Frost MH, et al: Benign breast disease and the risk of breast cancer. N Engl J Med 353:229-237, 2005
8. McDivitt RW, Stevens JA, Lee NC, et al: Histologic types of benign breast disease and the risk for breast cancer: The Cancer and Steroid Hormone Study Group. Cancer 69:1408-1414, 1992
9. McKian KP, Reynolds CA, Visscher DW, et al: Novel breast tissue feature strongly associated with risk of breast cancer. J Clin Oncol 27:5893-5898, 2009
10. Milanese TR, Hartmann LC, Sellers TA, et al: Age-related lobular involution and risk of breast cancer. J Natl Cancer Inst 98:1600-1607, 2006
11. Tyrer J, Duffy SW, Cuzick J: A breast cancer prediction model incorporating familial and personal risk factors. Stat Med 23:1111-1130, 2004
12. Pankratz VS, Hartmann LC, Degnim AC, et al: Assessment of the accuracy of the Gail model in women with atypical hyperplasia. J Clin Oncol 26:5374-5379, 2008
13. Boughey JC, Hartmann LC, Anderson SS, et al: Evaluation of the Tyrer-Cuzick (International Breast Cancer Intervention Study) model for breast cancer risk prediction in women with atypical hyperplasia. J Clin Oncol 28:3591-3596, 2010
14. Benichou J, Gail MH: Estimates of absolute cause-specific risk in cohort studies. Biometrics 46:813-826, 1990
15. Rosner B: Fundamentals of Biostatistics (ed 5). Pacific Grove, CA, Duxbury Press, 2000
16. Rubin DB: Multiple imputation after 18+ years. J Am Stat Assoc 91:473-489, 1996
17. Schafer JL: Multiple imputation: A primer. Stat Methods Med Res 8:3-15, 1999
18. Gail MH, Pee D: Breast Cancer Risk Assessment macro. http://dceg.cancer.gov/tools/risk-assessment/bcrasasmacro
19. Mealiffe ME, Stokowski RP, Rhees BK, et al: Assessment of clinical validity of a breast cancer risk model combining genetic and clinical information. J Natl Cancer Inst 102:1618-1627, 2010
20. Hosmer DW, Lemeshow S: Applied Logistic Regression. New York, NY, Wiley, 1989
21. Prentice RL, Pyke R: Logistic disease incidence models and case control studies. Biometrika 66:403-411, 1979
22. Tice JA, Cummings SR, Smith-Bindman R, et al: Using clinical factors and mammographic breast density to estimate breast cancer risk: Development and validation of a new predictive model. Ann Intern Med 148:3037-3047, 2008
23. Pencina MJ, D'Agostino RB Sr, D'Agostino RB Jr, et al: Evaluating the added predictive ability of a new marker: From area under the ROC curve to reclassification and beyond. Stat Med 27:157-172, 2008
24. Kerr KF, Wang Z, Janes H, et al: Net reclassification indices for evaluating risk-prediction instruments: A critical review. Epidemiology 25:114-121, 2014
25. Pepe MS, Kerr KF, Longton G, et al: Testing for improvement in prediction model performance. Stat Med 32:1467-1482, 2013
26. Dupont WD, Page DL: Risk factors for breast cancer in women with proliferative breast disease. N Engl J Med 312:146-151, 1985
27. London SJ, Connolly JL, Schnitt SJ, et al: A prospective study of benign breast disease and the risk of breast cancer. JAMA 267:941-944, 1992